Our skilled medical professionals can assess your B12 status through blood tests and recommend appropriate treatment tailored to your individual needs
In expanded populations, comparing semaglutide versus sitagliptin for the composite outcome of myocardial infarction or stroke yielded a hazard ratio of 0.82 (95% confidence interval (CI) 0.74 to 0.91), and comparing tirzepatide versus dulaglutide for the composite outcome including mortality yielded a hazard ratio of 0.87 (95% CI 0.75 to 1.01)
But like all peptides and hormone-related interventions, results depend on: Dosing and timing Lifestyle habits (training, sleep, nutrition) Quality of the peptide source Individual hormone levels and goals Before starting a peptide regimen, consult with a qualified medical providerespecially if youre stacking peptides, managing other health conditions, or subject to drug testing
Quick Answer: While generics exist for older GLP-1s like liraglutide and exenatide, there are currently no FDA-approved generic versions of semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)
These precautions are in place to ensure the safe and effective use of the medication, adhering to regulatory guidelines for its approved uses